Lynne F. McGrath - 13 Sep 2021 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
Director
Signature
/s/ Lynne F. McGrath
Issuer symbol
ALZN
Transactions as of
13 Sep 2021
Net transactions value
$0
Form type
4
Filing time
15 Sep 2021, 17:01:03 UTC
Previous filing
16 Jul 2021
Next filing
18 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALZN Common Stock Options Exercise $0 +2,778 $0.000000 2,778 13 Sep 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALZN Restricted Stock Grant Options Exercise $0 -2,778 -2.8% $0.000000 97,222 13 Sep 2021 Common Stock 2,778 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the vesting of restricted stock.
F2 Each restricted stock unit is the economic equivalent of one share of Common Stock, par value $0.0001, of Alzamend Neuro, Inc.
F3 The restricted stock grant vests in 36 equal monthly installments commencing on September 13, 2021.